Deamidation, acylation and proteolysis of a model peptide in PLGA films

Journal of Controlled Release : Official Journal of the Controlled Release Society
M L HouchinElizabeth M Topp

Abstract

The relative rates of deamidation, acylation and proteolysis (i.e. amide bond cleavage) were determined for a model peptide (VYPNGA) in poly (dl-lactide-co-glycolide) films. Films were stored at 70 degrees C and either 95%, 75%, 60%, 45%, 28%, or approximately 0% relative humidity and at 37 degrees C and 95% relative humidity. Peptide degradation products were identified by ESI+MS/MS and quantitated by LC/MS/MS. Extensive overlap of degradation mechanisms occurred, producing a complex mixture of products. Acylation was the dominant peptide degradation reaction (10-20% of total peptide) at early stages of PLGA hydrolysis and at intermediate relative humidity (60-45% RH). Deamidation and proteolysis were dominant (25-50% and 20-40% of total peptide, respectively) at later stages and at high relative humidity (95-75% RH). Understanding the relative rates of each peptide degradation reaction will allow for improved design of PLGA formulations that preserve the stability of peptide and protein drugs.

References

Jul 1, 1997·Journal of Biomedical Materials Research·C M Agrawal, K A Athanasiou
Oct 31, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·T G ParkY Sung Nam
Nov 5, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·P JohansenB Gander
Sep 9, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·M MiyajimaM Ikeda
Oct 9, 1999·Journal of Pharmaceutical Sciences·K Y KwokK G Rice
Apr 28, 2000·The Journal of Peptide Research : Official Journal of the American Peptide Society·M C LaiE M Topp
Jan 5, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Deborah M Schachter, Joachim Kohn
Feb 21, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ge JiangPatrick P DeLuca
Jun 6, 2002·Critical Reviews in Therapeutic Drug Carrier Systems·Steven P Schwendeman
Apr 2, 2003·Cardiovascular Toxicology·B J Marafino, M K Pugsley
Apr 23, 2003·Advanced Drug Delivery Reviews·Hiroki Ueda, Yasuhiko Tabata
Oct 22, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Dong Hee NaKang Choon Lee
Nov 25, 2004·Advanced Drug Delivery Reviews·Harjit TamberBruno Gander
Nov 30, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yoon Yeo, Kinam Park
Dec 14, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lei Li, Steven P Schwendeman
Jan 18, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Giuseppe De RosaFrancesca Ungaro
May 12, 2005·International Journal of Pharmaceutics·Santos B MurtyPatrick P DeLuca
Oct 4, 2005·International Journal of Pharmaceutics·Moon Suk KimHai Bang Lee
Nov 23, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xiaosong Luan, Roland Bodmeier
Dec 6, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alex GoraltchoukMolly S Shoichet

❮ Previous
Next ❯

Citations

Jun 18, 2009·Pharmaceutical Research·Ying ZhangSteven P Schwendeman
Sep 3, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Rongcai LiangYouxin Li
Apr 4, 2015·International Journal of Molecular Sciences·Noriyoshi ManabeOhgi Takahashi
Sep 11, 2007·Journal of Pharmaceutical Sciences·M L Houchin, E M Topp
Dec 3, 2014·Advanced Drug Delivery Reviews·Xiaohua YuWilliam L Murphy
Nov 27, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Mehrnoosh ShirangiCornelus F van Nostrum
May 2, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ying Zhang, Steven P Schwendeman
Jun 7, 2011·International Journal of Pharmaceutics·Susanne FredenbergAnders Axelsson
Oct 23, 2009·Biomaterials·Vincent F FioreThomas H Barker
Jan 9, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·M L HouchinE M Topp
Jan 13, 2015·International Journal of Pharmaceutics·Milica StankovićWouter L J Hinrichs
Mar 24, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ohgi TakahashiRyota Kirikoshi
Mar 27, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Young H LimKaren L Wooley
Oct 31, 2020·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Tinghui LiSteven P Schwendeman
Sep 5, 2020·Biomacromolecules·Justin K Y Hong, Steven P Schwendeman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
M L HouchinElizabeth M Topp
Journal of Controlled Release : Official Journal of the Controlled Release Society
Mohamed Abbas IbrahimAchim Göpferich
© 2021 Meta ULC. All rights reserved